Skip to main content
. 2021 May 28;9:679325. doi: 10.3389/fcell.2021.679325

FIGURE 4.

FIGURE 4

Expression of otic vesicle markers in Meis2flox/flox; Pax2Cre/+ mutants. Expression of the indicated markers was detected via mRNA in situ hybridization (E–H,K,L) or immunohistochemistry (C,D,I,J,M,N). (A,B) Bright field image of controls and mutants showing a reduced sized otic vesicle at E10,5. (C,D) Sections at E10 reveal widespread pH3 immunoreactivity in the otic vesicles (circumference indicated by stippled lines) of controls and mutants. (E–L) No changes in the spatial domains of the otic markers (borders indicated by arrows) is observed in the mutants at E9 (E–H) and E10 (I–L). (M,N) At E11 the ventral domain of Sox2 expression is smaller in mutants correlating with the reduced sized dimensions of the otic vesicle at this stage. Scale bars in (C,E,I): 50 μm; in (K): 100 μm and in (M): 75 μm.